Alector to Participate in Upcoming Healthcare Conferences

Rhea-AI Summary

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company, will be participating in the Bank of America Securities Health Care Conference and H.C. Wainwright 2nd Annual BioConnect Investor Conference. The company's management will give presentations at these events, showcasing their work in immuno-neurology. Webcasts of the presentations will be available on the Alector website.

SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:

• Bank of America Securities Health Care Conference (Las Vegas, Nevada)
  • Tuesday, May 14, 2024, at 8:55 a.m. PT, corporate presentation
• H.C. Wainwright 2^nd Annual BioConnect Investor Conference (New York, New York)
  • Monday, May 20, 2024, at 11:00 a.m. ET, fireside chat

A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com. Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.

About Alector
Alector is a clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector has discovered and is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain’s immune system and enable rejuvenated immune cells to counteract emerging brain pathologies. Alector’s immuno-neurology product candidates are supported by biomarkers and seek to treat indications, including Alzheimer’s disease and genetically defined frontotemporal dementia patient populations. Alector is headquartered in South San Francisco, California.

Alector Contacts:
Alector
Katie Hogan
202-549-0557
katie.hogan@alector.com

1AB (media)
Dan Budwick
973-271-6085
dan@1abmedia.com

Argot Partners (investors)
Laura Perry
212.600.1902
alector@argotpartners.com

FAQ

When will Alector participate in the Bank of America Securities Health Care Conference?

Alector will participate in the Bank of America Securities Health Care Conference on Tuesday, May 14, 2024, at 8:55 a.m. PT.

What is the focus of Alector's work at the upcoming investor conferences?

Alector will be showcasing its work in immuno-neurology at the upcoming investor conferences.

Where can I watch the webcasts of Alector's conference presentations?

The webcasts of the conference presentations will be available on the 'Events & Presentations' page within the Investors section of the Alector website at http://investors.alector.com.

How long will the replays of the webcasts be available?

Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.